Skip to main content
International Journal of Women's Dermatology logoLink to International Journal of Women's Dermatology
. 2023 Jul 13;9(3):e092. doi: 10.1097/JW9.0000000000000092

Colorism attitudes and use of skin lightening agents in the United States

Karishma Daftary a, Sneha Poondru a, Nina Patel b, Maxwell Shramuk c, Lutfiyya Muhammad c, Roopal V Kundu a,*
PMCID: PMC10344531  PMID: 37457383

Abstract

Background:

Skin lightening (SL) is a practice involving the use of chemicals to lighten the skin that is more common among skin of color (SOC) individuals, particularly women, and can lead to adverse health consequences.

Objective:

In this study, we examine SL habits, including both general lightening and lightening for the treatment of a skin condition, among SOC individuals in the United States and the role of colorism in motivating these behaviors.

Methods:

A cross-sectional survey was administered to SOC individuals through ResearchMatch, an online national health registry. Demographics, rates of SL, SL habits, and perceived colorism among SL users and nonusers were collected and analyzed with χ2, Fisher’s exact, Analysis of variance (ANOVA), Spearman correlation, and t tests.

Results:

A total of 455 participants completed the survey. Ninety-seven participants (21.3%) reported using SL agents: 73.2% (71/97) used SL agents for the treatment of a skin condition and 26.8% (26/97) used the products for general SL. Only 22.6% (22/97) of SL users consulted a medical provider before using the products. Forty-four participants (45.4%) were unaware of their SL product ingredients, and 35.1% (34/97) reported using hydroquinone-based products. Composite colorism scores were significantly higher in SL users than nonusers (20.03 vs 18.20; P < .001).

Limitations:

This study used self-reported racial/ethnic groups to characterize those with SOC rather than assessing actual skin tones of participants, which could have led to variability.

Conclusion:

SL among SOC individuals is prevalent in the U.S. and poses a health risk, as many SL users are unaware of product ingredients, do not consult a medical provider before use, and have access to potentially unsafe formulations. Dermatologists should address skin tone and pigmentary concerns with their SOC patients.

Keywords: colorism, skin bleaching, skin lightening, skin of color


What is known about this subject in regard to women and their families?

  • Skin lightening (SL) is the practice of using chemicals to lighten dark areas of skin or achieve a generally lighter skin tone. Studies in multiple Asian and African countries have found that SL is prevalent among those with skin of color (SOC).

  • Attitudes of colorism—the system of inequality that views lighter skin as more beautiful and advantageous—are often propagated by social media and popular culture, driving individuals to participate in potentially risky SL behaviors.

What is new from this article as message for women and their families?

  • Although we found no differences in SL use between the genders, our sample consisting of largely women (80%) demonstrated that SL is a prevalent practice among SOC individuals in the U.S.

  • Those that use SL products reported stronger perceived colorism than nonusers.

  • SL poses a health risk since many users are unaware of the ingredients in their products, have access to potentially unsafe formulations, and do not consult a medical provider before use.

Introduction

Skin lightening (SL) and bleaching—the use of chemicals to lighten the skin—is an expanding and largely unregulated multi-billion-dollar global industry that is influenced by colorism, the system of inequality that affords opportunities and privileges to lighter-skinned individuals across racial/ethnic groups.1,2 Women, in particular, are vulnerable as media and popular culture propagate beauty standards that lighter skin can elevate their physical appearance and social acceptance.1,3 SL poses a potential threat to consumers and raises challenges for dermatologists due to products containing ingredients that may lead to adverse health consequences, particularly with prolonged use and lack of medical consultation.4 Rates of SL vary globally from 27% in South Africa to 77% in Nigeria and 40% in China and South Korea; however, little is known about SL prevalence and habits within the United States (U.S.).5 The objective of this study is to examine SL habits among skin of color (SOC) individuals in the U.S. and the role of colorism in motivating these behaviors.

Methods

This cross-sectional survey study was exempted by the Northwestern University Institutional Review Board. An anonymous, electronic, 19-item questionnaire was distributed to participants through ResearchMatch, a national online health volunteer registry supported by the US National Institutes of Health. Individuals were contacted directly through messaging on the ResearchMatch platform. Only SOC individuals were contacted, defined as those self-identifying as American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or other Pacific Islander, multiracial, Hispanic, or other race.

The survey collected information on participant demographics, colorism attitudes, skin tone satisfaction, and if applicable, SL habits. To assess colorism attitudes, participants were asked to score 6 statements adapted from Hamed et al.6 on a Likert scale of 1 (strongly disagree) to 5 (strongly agree). The scores were summed into a composite colorism score ranging from 6 to 30, with higher scores signifying stronger perceived colorism. Likewise, skin satisfaction levels were scored on a Likert scale of 1 (very unsatisfied) to 5 (very satisfied). Data were analyzed with χ2, Fisher’s exact, Analysis of variance (ANOVA), Spearman correlation, and t tests using R version 4.2.1. A Bonferroni-adjusted P value of < .001 was considered statistically significant.

Results

In total, 578 participants were contacted, and 455 completed the survey for a response rate of 78.7%. The respondents identified as Black or African American (52.3%; n = 238/455), Asian (18.2%; n = 83/455), multiracial (18.5%; n = 84/455), Hispanic (6.8%; n = 31/455), American Indian or Alaska Native (3.1%; n = 14/455), and other (1.1%; n = 5/455). Regarding immigration status, 14.7% (67/455) identified as first generation (foreign-born individuals) and 31.2% (142/455) as second generation (US-born individuals with at least 1 foreign-born parent). Additional demographics are summarized in Table 1.

Table 1.

Demographics of survey participants

No. (%)
Characteristic All participants (n = 455; 100%) Skin lightening agent users Skin lightening agent nonusers
(n = 97; 21.3%) (n = 358; 78.7%)
Age (median [25%–75%]) 41 (29–54) 44 (30–56) 39 (29–35)
Gender
 Man 74 (16.3) 10 (10.3) 64 (17.8)
 Woman 364 (80.0) 82 (84.5) 282 (78.7)
 Nonbinary 16 (3.5) 4 (4.1) 12 (3.4)
 Other 1 (0.2) 1 (1.0) 0 (0)
Race/ethnicity
 Black or African American 238 (52.3) 61 (62.9) 177 (49.4)
 Asian 83 (18.2) 20 (20.6) 63 (17.6)
  East Asian 46 (10.1) 10 (10.3) 36 (10.1)
  South Asian 34 (7.5) 9 (9.3) 25 (7.0)
  Other Asian 3 (0.7) 1 (1.0) 2 (0.6)
 Hispanic 31 (6.8) 5 (5.2) 26 (7.3)
 American Indian or Alaska Native 14 (3.1) 2 (2.1) 12 (3.3)
 Other race 5 (1.1) 1 (1.0) 4 (1.1)
 Multiracial 84 (18.5) 8 (8.2) 76 (21.2)
Region of residence
 Northeast 93 (20.4) 17 (17.5) 76 (21.2)
 Midwest 92 (20.2) 20 (20.6) 72 (20.1)
 South 202 (44.4) 45 (46.4) 157 (43.9)
 West 68 (14.9) 15 (15.5) 53 (14.8)
Highest level of education
 Less than high school 3 (0.7) 0 (0) 3 (0.8)
 High school diploma 67 (14.7) 13 (13.4) 54 (15.1)
 Associate degree 66 (14.5) 20 (20.6) 46 (12.8)
 Bachelor’s degree 153 (33.6) 31 (32.0) 122 (34.1)
 Graduate degree 166 (36.5) 33 (34.0) 133 (37.2)
Immigration generational statusa
 First generation 67 (14.7) 15 (15.5) 52 (14.5)
 Second generation 142 (31.2) 36 (37.1) 106 (29.6)
a

First-generation individuals are defined in this study as foreign-born individuals; Second-generation individuals are defined as US-born individuals with at least 1 parent who is foreign-born.

Ninety-seven participants (21.3%) reported using SL agents. Of that group, 73.2% (71/97) used SL agents for the treatment of a skin condition, such as acne, melasma, or postinflammatory hyperpigmentation, whereas 26.8% (26/97) used the products for general SL (Table 2). Only 22.6% (22/97) of SL agent users consulted a medical provider before using products. Forty-four participants (45.4%) could not identify the active ingredient in their SL products. Of the reported active ingredients, hydroquinone (35.1%; 34/97), ascorbic acid (21.6%; 21/97), glycolic acid (18.6%; 18/97), salicylic acid (16.5%; 16/97), and niacinamide (15.5%; 15/97) were the most common. The most common sites of application were the face (88.7%; 86/97) and neck (38.1%; 37/97). Participants obtained SL products from chain pharmacy and grocery stores (42.2%; 41/97), community beauty stores or abroad (23.7%; 23/97), online (15.5%; 15/97), medical providers (14.4%; 14/97), and home (2.1%; 2/97). There were no significant differences in SL based on age, gender, race/ethnicity, immigration status, or education level.

Table 2.

Skin lightening habits of study participants

Characteristic No. (%)
n = 97
Purpose of skin lightening product
 Treatment of skin problem 71 (73.2)
 General lightening 26 (26.8)
Medical consultation before use of product
 No 75 (77.3)
 Yes 22 (22.7)
Areas of body product was applied
 Face 86 (88.7)
 Neck 37 (38.1)
 Legs 24 (24.7)
 Arms 21 (21.6)
 Underarms 18 (18.6)
 Hands 15 (15.5)
 Back 11 (11.3)
 Chest 10 (10.3)
 Feet 10 (10.3)
 Abdomen 9 (9.3)
Active ingredients in product
 Unknown 44 (45.4)
 Hydroquinone 34 (35.1)
 Ascorbic acid (vitamin C) 21 (21.6)
 Glycolic acid 18 (18.6)
 Salicylic acid 16 (16.5)
 Niacinamide 15 (15.5)
 Kojic acid 14 (14.4)
 Tretinoin 14 (14.4)
 Tocopherol (vitamin E) 11 (11.3)
 Licorice extract 9 (9.3)
 Arbutin 8 (8.2)
 Soy extract 7 (7.2)
 Azelaic acid 5 (5.2)
 Mequinol 4 (4.1)
 Titanium dioxide 4 (4.1)
 Tranexamic acid 4 (4.1)
 Steroids 3 (3.1)
 Mercury 2 (2.1)
Where product was obtained
 Chain pharmacy or grocery store 41 (42.2)
 Community beauty store or abroad 23 (23.7)
 Online 15 (15.5)
 Medical provider or prescription 14 (14.4)
 Homemade 2 (2.1)
 Other 3 (3.1)

Composite colorism scores were significantly higher in those that used SL agents than in those that did not (20.03 vs 18.20; P < .001) (Table 3). Specifically, SL agent users more strongly agreed with the statements that lighter skin is more beautiful (P < .001), increases one’s self-esteem (P < .001), and increases one’s chance of having a romantic relationship or getting married (P < .001). There was no statistically significant difference between SL agent users and nonusers on the statements that lighter skin tone is portrayed as more beautiful in the media (P = .187), increases one’s job opportunities (P = .884), and increases one’s chance of having friendships (P = .046). Additionally, SL agent users had lower skin tone satisfaction levels than nonusers (3.86 vs 4.33; P < .001). Black participants had higher skin tone satisfaction than Asian (P < .001), Hispanic (P < .001), and multiracial participants (P < .001). Age directly correlated with skin tone satisfaction (r = 0.2377; P < .001) and inversely correlated with composite colorism score (r = −0.209; P < .001).

Table 3.

Comparison of colorism scores in those that practice skin lightening and those who do not

Colorism statement Average score Average score P value
(skin-lightening users) (no skin lightening)
Lighter skin tone is more beautiful 2.412 1.936 <.001
Lighter skin tone is portrayed as more beautiful in the media 4.433 4.288 .187
Lighter skin tone increases one’s job opportunities 3.804 3.788 .894
Lighter skin tone increases one’s self-esteem 3.268 2.863 <.001
Lighter skin tone increases one’s chance of having a romantic relationship or getting married 3.278 2.771 <.001
Lighter skin tone increases one’s chance of having friendships 2.835 2.559 .046
Composite colorism score 20.031 18.204 <.001

Discussion

This study examines SL prevalence, habits, and motivations within the U.S. Among our study population, 21.3% of SOC participants reported using SL agents, of which the majority (73.2%) used SL agents for the treatment of a skin condition and the minority (26.8%) used the products for general SL. Specifically, only 5.7% of all participants used SL products for generalized SL. This is slightly less than the estimated global prevalence of using SL agents of 27% and substantially lower than similar studies conducted in some Asian and African countries.5,7 Nevertheless, these results suggest that SL is prevalent among SOC individuals in the U.S.

A large proportion of SL agent users in the present study remained unaware of the active ingredients in their products (45.4%) and did not consult a medical provider before use (77.3%), suggesting that consumers may not fully understand the risks of bleaching agents in their products. Hydroquinone was the most common active ingredient reported (35.1%). Prolonged use or misuse of hydroquinone may lead to adverse effects, including contact dermatitis, exogenous ochronosis, ocular melanosis, and nail hyperpigmentation.4,5 Following the Coronavirus Aid, Relief, and Economic Security Act of 2020, over-the-counter hydroquinone sales were prohibited in the U.S.8 However, this study demonstrates that consumers in the U.S. may still have access to hydroquinone formulations through community beauty stores, online retailers, and purchases made while abroad.

SL agent users had a significantly stronger belief in colorism than nonusers, including beliefs that lighter skin was more beautiful, increased self-esteem, and increased romantic prospects (P < .001). These findings are consistent with similar studies conducted among women in Jordan, Saudi Arabia, South Africa, and Somalia who engage in SL.3,6,9,10 Though most participants in this study reported SL to treat a skin condition (73.2%) as opposed to general SL (26.8%), the significantly stronger belief in colorism points to this as a co-existing and potentially subconscious motivation. Additionally, SL agent users had significantly lower skin tone satisfaction levels compared to nonusers (P < .001). These findings may be partly attributable to the colorism ideals that continue to be propagated in popular culture, social media, and institutions in the U.S. today.5,11

This study has certain limitations. First, it is impossible to account for the heterogeneity of SOC individuals in the U.S. with broad racial/ethnic categories, which likely obscures true differences between groups.12 In addition, this study used self-reported racial/ethnic categories to include those with SOC and did not assess the actual skin tones of participants. This could have led to variability as some individuals identifying as White could have darker skin tones and those of the included racial/ethnic groups could have lighter skin tones (Fitzpatrick skin phototype I-III). Additionally, since the participants contacted were aware of the topic of the survey, there is potential response bias as SL agent users may have been more inclined to participate, overestimating the rate of SL use. Finally, the smaller proportion of certain racial/ethnic groups, education levels, and male participants may further skew the data.

Conclusion

SL is prevalent in the SOC community and poses a potential health risk, as many SL users are unaware of the ingredients in their products, do not consult a medical provider before use, and have access to potentially unsafe formulations. These findings underscore the important role of dermatologists in addressing skin tone and pigmentary concerns with their SOC patients, as patients may be using SL agents for a variety of reasons: most commonly for self-treatment of a skin condition but also for general SL. We urge dermatologists to recognize the historical and sociocultural motivations for SL and uncover patient beliefs about the perceived risks and benefits of SL. Initiatives to increase public awareness about the harmful effects of colorism and celebrate all skin tones in SOC communities will further enable dermatologists to promote skin health and limit risky SL practices.

Conflicts of interest

None.

Funding

None.

Study approval

This study was deemed exempt by the Northwestern University Institutional Review Board.

Author contributions

KD participated in research design, performance of the research, data analysis, and writing of the paper. SP participated in data analysis and writing of the paper. NP participated in writing of the paper. MS and LM participated in data analysis. RVK participated in research design, performance of research, writing of the paper, and supervision.

Footnotes

Published online 13 July 2023

References

  • 1.Daftary K, Krishnam NS, Kundu RV. Uncovering the roots of skin bleaching: colorism and its detrimental effects. J Cosmet Dermatol 2023;22(1):337–8. doi:10.1111/jocd.15049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Hargrove TW. Light privilege? Skin tone stratification in health among African Americans. Sociol Race Ethn 2019;5:370–87. doi:10.1177/2332649218793670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Alrayyes SF, Alrayyes SF, Farooq Dar U. Skin-lightening practices behind the veil: an epidemiological study among Saudi women. J Cosmet Dermatol 2020;19:147–53. doi:10.1111/jocd.12972. [DOI] [PubMed] [Google Scholar]
  • 4.Sommerlad M. Skin lightening: causes and complications. Clin Exp Dermatol 2022;47:264–70. doi:10.1111/ced.14972. [DOI] [PubMed] [Google Scholar]
  • 5.Pollock S, Taylor S, Oyerinde O, et al. The dark side of skin lightening: an international collaboration and review of a public health issue affecting dermatology. Int J Womens Dermatol 2021;7:158–64. doi:10.1016/j.ijwd.2020.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Hamed SH, Tayyem R, Nimer N, Alkhatib HS. Skin-lightening practice among women living in Jordan: prevalence, determinants, and user’s awareness. Int J Dermatol 2010;49:414–20. doi:10.1111/j.1365-4632.2010.04463.x. [DOI] [PubMed] [Google Scholar]
  • 7.Sagoe D, Pallesen S, Dlova NC, Lartey M, Ezzedine K, Dadzie O. The global prevalence and correlates of skin bleaching: a meta-analysis and meta-regression analysis. Int J Dermatol 2019;58:24–44. doi:10.1111/ijd.14052. [DOI] [PubMed] [Google Scholar]
  • 8.Falotico JM, Lipner SR. Advocacy needed for increased hydroquinone accessibility following the 2020 CARES Act. J Cosmet Dermatol 2022;21:2693–4. doi:10.1111/jocd.15015. [DOI] [PubMed] [Google Scholar]
  • 9.Yusuf MA, Mahmoud ND, Rirash FR, Stoff BK, Liu Y, McMichael JR. Skin lightening practices, beliefs, and self-reported adverse effects among female health science students in Borama, Somaliland: a cross-sectional survey. Int J Womens Dermatol 2019;5:349–55. doi:10.1016/j.ijwd.2019.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Rahiman F, Davids LM, Hons AT. A survey evaluating knowledge, perception, and use of skin lightening products among South African students. Int J Womens Dermatol 2021;7:766–8. doi:10.1016/j.ijwd.2021.07.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Landor AM, McNeil Smith S. Skin-tone trauma: historical and contemporary influences on the health and interpersonal outcomes of African Americans. Perspect Psychol Sci 2019;14:797–815. doi:10.1177/1745691619851781. [DOI] [PubMed] [Google Scholar]
  • 12.Williams HC. Have you ever seen an Asian/Pacific Islander? Arch Dermatol 2002;138:673–4. doi:10.1001/archderm.138.5.673. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Women's Dermatology are provided here courtesy of Wolters Kluwer Health

RESOURCES